Europe’s drugs regulator has for the first time recommended a gene therapy for approval

A gene therapy medicine was backed for the first time by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).

In the prestigious British review Nature, Fulvio Mavilio, Scientific Director of Genethon, is delighted about this news which is an encouragement, for Genethons projects and for the Gene Therapy area as a whole.